Loyal

United States
Wrightstown, Wisconsin, United States, 94103

Company profile

Loyal company profile

Loyal is a veterinary biotechnology company that develops pharmaceutical therapies for dogs aimed at extending their healthy lifespan and delaying age-associated diseases. It researches and formulates drug candidates designed to address the biological mechanisms of aging in different dog populations, including senior and large-breed dogs, with products progressing through clinical and regulatory pathways. Loyal engages in clinical studies and collaborates with veterinary professionals to advance its therapeutic programs and share scientific insights with the broader field. The company publishes research summaries to support transparency and enable other practitioners to build on its findings.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
2019-01-01, Year

Headquarters

Postal code
94103
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
9
Total equity funding
$225.1M
Last funding
Series C / $100M / 2026-02-11
Last equity funding
Series C / $100M
Investors
23
Lead investors
6
Founders
1
Articles
18

Founders and investors

Founders

Celine Halioua

Lead investors

age1Bain Capital VenturesBridge BankCollaborative FundKhosla VenturesValor Equity Partners

Investors

Bain Capital VenturesBoxGroupCollaborative FundKhosla VenturesValor Equity Partners